Christopher Raymond

Sr. Research Analyst
Sector Expertise
Additional Expertise
Chris Raymond is a managing director and senior research analyst at Piper Sandler covering the biotechnology sector. Prior to joining Piper, he spent the previous 17 years covering biotechnology at Raymond James, Robert W. Baird and Prudential Vector Healthcare Group. Before that, he spent 10 years with Baxter Healthcare and G. D. Searle in various marketing, business development and strategy roles. Raymond has been recognized twice by StarMine as a top earnings estimator in biotechnology and in 2004 was recognized byThe Wall Street Journal "Best on the Street" survey. Raymond received his bachelor’s degree from Michigan State University and his Master of Business Administration degree from the University of Chicago Graduate School of Business. He currently serves on the board of the Financial Markets Institute at Michigan State's Broad College of Business.

Universe Coverage

ABBVAbbVie Inc.
ACRSAclaris Therapeutics, Inc.
AGIOAgios Pharmaceuticals, Inc.
ALVRAlloVir, Inc.
ALXOALX Oncology Holdings, Inc.
AMGNAmgen Inc.
ARDXArdelyx, Inc.
BCRXBioCryst Pharmaceuticals, Inc.
BIIBBiogen Inc.
BHVNBiohaven Pharmaceutical Holding Company Ltd
BMRNBioMarin Pharmaceutical Inc.
BPMCBlueprint Medicines Corporation
COGTCogent Biosciences, Inc.
INZYInozyme Pharma, Inc.
IOBTIO Biotech, Inc.
ITOSiTeos Therapeutics, Inc.
KPTIKaryopharm Therapeutics, Inc.
MGTXMeiraGTx Holdings Plc
NUVLNuvalent, Inc.
QTTBQ32 Bio, Inc.
REGNRegeneron Pharmaceuticals Inc.
TSHATaysha Gene Therapies, Inc.
RAREUltragenyx Pharmaceutical, Inc.
VRTXVertex Pharmaceuticals Inc.